Core Viewpoint - First American Uranium Inc. will consolidate its common shares on a 1-for-2 basis effective August 6, 2025, while retaining its name and stock symbol [1][4]. Share Consolidation Details - The company currently has 12,247,181 shares, which will reduce to approximately 6,123,590 post-consolidation shares [2]. - No fractional shares will be issued; any resulting fractions will be rounded to the nearest whole share [3]. - Outstanding incentive stock options and warrants will also be adjusted on a 1:2 basis, including proportional adjustments to exercise prices [3]. Trading Information - Post-consolidation shares are expected to begin trading on the Canadian Securities Exchange (CSE) on or about August 6, 2025 [4]. Shareholder Instructions - Registered shareholders will receive letters of transmittal and must send their pre-consolidation share certificates to the company's transfer agent, Endeavor Trust Corporation, to receive post-consolidation shares [5]. Company Overview - First American Uranium Inc. is focused on mineral exploration and acquisition of mineral property assets in North America, particularly in the Silver Lake and Red Basin properties [6].

Core Viewpoint - SOL Strategies Inc. is moving forward with a stock consolidation to meet NASDAQ listing requirements, which is expected to enhance its visibility in U.S. capital markets and attract institutional investors interested in the Solana blockchain ecosystem [1][3]. Group 1: Stock Consolidation Details - The Board of SOL Strategies has approved a consolidation of its common shares on a basis of one new share for every eight existing shares [1]. - The consolidation was previously approved by shareholders at the Annual General Meeting on June 19, 2025, and is subject to approval from the Canadian Securities Exchange [1]. - The anticipated effective date for the consolidation is around August 5, 2025 [1]. Group 2: Impact on Shareholders - Shareholders' percentage ownership and voting power will remain unchanged post-consolidation, with minor adjustments for fractional shares [1]. - No fractional shares will be issued; instead, they will be rounded down to the nearest whole share, with cash provided for any fractional amounts [2]. Group 3: Company Strategy and Future Plans - The CEO of SOL Strategies emphasized the commitment to meeting NASDAQ's listing standards and the potential for expanding access to institutional investors [3]. - The company aims to enhance its visibility in U.S. capital markets and continue building the institutional backbone of the Solana ecosystem [3]. - The company's name and stock symbol will remain unchanged after the consolidation [2]. Group 4: Company Overview - SOL Strategies Inc. is a Canadian investment company focused on the Solana blockchain ecosystem, providing strategic investments and infrastructure solutions for decentralized applications [4].

Core Points - Digitalist Group Plc is convening an Extraordinary General Meeting on August 13, 2025, to discuss significant corporate actions including share consolidation [1][2] Group A: Share Consolidation and Related Actions - The Board of Directors proposes a share consolidation where every 250 existing shares will be consolidated into one new share, resulting in a total of approximately 693,430,455 shares being reduced to about 2,773,722 shares post-consolidation [2][3] - The objective of the share consolidation is to enhance trading conditions by increasing the value per share and improving price formation, with no impact on the Company's equity [3][4] - To facilitate the consolidation, the Company plans to transfer its own treasury shares and redeem shares from shareholders at a ratio of 249/250, leading to an estimated redemption of approximately 691,500,000 shares [5][7] Group B: Implementation and Technical Details - The share consolidation is scheduled to be executed in the book-entry system after trading closes on August 15, 2025, with the new total number of shares expected to be registered by August 18, 2025 [8][9] - The Board is authorized to manage all aspects related to the transfer of treasury shares and the redemption process [5][10] Group C: Authorizations and Future Actions - The Board seeks authorization to issue new shares and grant special rights entitling to shares, with a maximum of 1,386,000 shares to be issued, representing about 50% of the total shares post-consolidation [11][12] - The Board also proposes to authorize the acquisition of up to 270,000 treasury shares, which is approximately 10% of the total shares after consolidation, to support corporate acquisitions and improve capital structure [17][19] Group D: Meeting Logistics and Participation - Shareholders must register for the meeting by 4 p.m. on August 8, 2025, and can participate either in person or through a proxy [22][23] - The meeting will be conducted primarily in Finnish, and shareholders have the right to request information regarding the agenda items [31][33]

Group 1 - The Company announced a share consolidation and change of ISIN, effective on 20 June 2025, as resolved by the Extraordinary General Meeting on 11 April 2025 [1][2] - The Subsequent Offering will be completed prior to the share consolidation, which has been postponed from 11 June 2025 to 20 June 2025 for technical reasons [2] - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3]

Core Points - Golden Heaven Group Holdings Ltd. announced a share consolidation on a 25 for 1 ratio, effective May 9, 2025, to comply with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing [1][2] - The share consolidation will convert every 25 ordinary shares into one ordinary share automatically, with no fractional shares issued [3] - The authorized share capital will change from US$200,600,000 into a new structure, resulting in approximately 2,972,944 Class A ordinary shares and approximately 73,600 Class B ordinary shares [4] Company Overview - Golden Heaven operates amusement parks, water parks, and complementary recreational facilities in China, offering a variety of experiences including rides, water attractions, and performances [5]

Core Points - Linkage Global Inc has announced a share consolidation on a 10 for 1 ratio effective April 7, 2025, to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on Nasdaq [1][2] - The share consolidation will result in each 10 ordinary shares automatically combining into one ordinary share, with no fractional shares issued [3] - Following the consolidation, the Company's authorized share capital will change from US$2,500,000 divided into 9,980,000,000 Class A ordinary shares to US$2,500,000 divided into 998,000,000 Class A ordinary shares, with the par value increasing from US$0.00025 to US$0.0025 [4] Company Overview - Linkage Global Inc is a holding company incorporated in the Cayman Islands, operating through subsidiaries in Japan, Hong Kong, and mainland China [5] - The Company specializes in cross-border e-commerce integrated services, with two main business lines: cross-border sales and integrated e-commerce services [5]

Core Viewpoint - China SXT Pharmaceuticals, Inc. has regained compliance with Nasdaq's Minimum Bid Price Requirement after a share consolidation and has closed the matter with Nasdaq [1][4]. Group 1: Compliance Notification - The company received a Compliance Notice from Nasdaq on March 13, 2025, confirming it has met the Minimum Bid Price Requirement [1]. - Previously, on October 3, 2024, the company was notified of its failure to maintain a minimum bid price of US$1.00 per share for 30 consecutive business days [2]. - The company was given until April 1, 2025, to regain compliance under Nasdaq Listing Rules [2]. Group 2: Share Consolidation - To address the Minimum Bid Price deficiency, the company executed a share consolidation on February 25, 2025, consolidating every eight ordinary shares into one [3]. - Following the consolidation, the company achieved a closing bid price of at least US$1.00 per share for 10 consecutive business days from February 25, 2025, to March 12, 2025 [4]. Group 3: Company Overview - China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou City, Jiangsu Province, China [5]. - The company specializes in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (TCMPs) and TCM Homologous Supplements (TCMHS) [5].

Core Points - Farmmi, Inc. announced a share consolidation at a ratio of one-for-twelve, effective March 17, 2025, to comply with Nasdaq listing requirements [1][2] - The consolidation will reduce the number of issued and outstanding ordinary shares from 15,007,123 to approximately 1,250,500 and authorized shares from 500,000,000 to 41,666,667 [4] Company Overview - Farmmi, Inc. is an agricultural products supplier, processor, and retailer specializing in edible mushrooms and other agricultural products, established in 1998 [5]